A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes Review

cited authors

  • Aroda, Vanita R.; Blonde, Lawrence; Pratley, Richard E.

authors

Publication Date

  • July 15, 2022

webpage

published in

category

keywords

  • GLP-1RA
  • Glucagon-like peptide-1 receptor agonists
  • Oral
  • Peptides
  • SNAC
  • Semaglutide
  • Sodium N-(8-[2-hydroxybenzoyl]amino)caprylate
  • Type 2 diabetes

start page

  • 979

end page

  • 994

volume

  • 23

issue

  • 5